International Stem Cell Corp (ISCO)
0.065
-0.01
(-8.71%)
USD |
OTCM |
Apr 24, 10:45
International Stem Cell Free Cash Flow (Quarterly): 0.158M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.158M |
| September 30, 2023 | 0.048M |
| June 30, 2023 | 0.439M |
| March 31, 2023 | 0.201M |
| December 31, 2022 | 0.076M |
| September 30, 2022 | 0.08M |
| June 30, 2022 | 0.188M |
| March 31, 2022 | -0.023M |
| December 31, 2021 | -0.334M |
| September 30, 2021 | -0.245M |
| June 30, 2021 | -0.367M |
| March 31, 2021 | -0.396M |
| December 31, 2020 | -0.337M |
| September 30, 2020 | -0.289M |
| June 30, 2020 | -0.047M |
| March 31, 2020 | 0.224M |
| December 31, 2019 | -0.479M |
| September 30, 2019 | -0.132M |
| June 30, 2019 | -0.82M |
| March 31, 2019 | -0.46M |
| December 31, 2018 | -0.098M |
| September 30, 2018 | -0.691M |
| June 30, 2018 | -0.705M |
| March 31, 2018 | -0.249M |
| December 31, 2017 | -0.706M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.487M |
| June 30, 2017 | -1.079M |
| March 31, 2017 | -0.734M |
| December 31, 2016 | -1.122M |
| September 30, 2016 | -0.656M |
| June 30, 2016 | -1.173M |
| March 31, 2016 | -2.19M |
| December 31, 2015 | -0.882M |
| September 30, 2015 | -0.726M |
| June 30, 2015 | -2.319M |
| March 31, 2015 | -0.931M |
| December 31, 2014 | -2.202M |
| September 30, 2014 | -1.285M |
| June 30, 2014 | -1.729M |
| March 31, 2014 | -2.187M |
| December 31, 2013 | -1.787M |
| September 30, 2013 | -1.481M |
| June 30, 2013 | -1.251M |
| March 31, 2013 | -2.015M |
| December 31, 2012 | -1.726M |
| September 30, 2012 | -1.84M |
| June 30, 2012 | -1.675M |
| March 31, 2012 | -2.241M |
| December 31, 2011 | -1.562M |
| September 30, 2011 | -2.854M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-0.82M
Minimum
Jun 2019
0.439M
Maximum
Jun 2023
-0.1082M
Average
-0.047M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | -9.097M |
| Protalix BioTherapeutics Inc | 3.345M |
| Electromed Inc | 3.384M |
| Armata Pharmaceuticals Inc | -10.51M |